[Thermo Fisher Scientific] Parallel Sequencing of Tumor DNA and RNA Expands Therapeutic Options for Late-Stage Non-Small Cell Lung Cancer Patients, Study Finds 글 내용 전체보기
[Thermo Fisher Scientific] Webinar : Cell Culture Contamination and Using Filtration as a Final Preventative Measure 글 내용 전체보기
Partnership to offer Digital Therapeutics for Diabetes and Cardiovascular Diseases Announced by Cipla and Wellthy Therapeutics 글 내용 전체보기
Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) Reduced Risk of Death by Nearly Half Compared to Sunitinib as First-Line Treatment for Advanced Renal Cell Carcinoma (RCC) 글 내용 전체보기
Pfizer Announce Pivotal Phase III Data for BAVENCIO® (AVELUMAB) Plus INLYTA® (AXITINIB) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine 글 내용 전체보기
At the 2019 ASCO Genitourinary Cancers Symposium Nektar Presents Clinical Data from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Metastatic Urothelial Carcinoma Patients 글 내용 전체보기
Acceleron to Webcast Fourth Quarter and Full Year 2018 Operating and Financial Results on February 27, 2019 글 내용 전체보기
Longeveron Discusses Latest Stem Cell Findings for Aging Frailty at the International Conference on Frailty & Sarcopenia Research 글 내용 전체보기
